Blog Layout

Market Commentary | January 2021

Rob Kellogg, CFA®

Feb 05, 2021

As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.

THE MARKET

Equity markets experienced a historic month in November as the S&P 500 finished up 10.75% and is now up 12.10% on the year. 

The Dow Jones Industrial Average (DJIA) is now up 3.86% on the year after finishing the month of November up 11.84%. The technology heavy NASDAQ continues to perform well in 2020 as it is now up 35.96% on the year after finishing the month up 11.80%. Small cap stocks led the monthly performance numbers as the Russell 2000 is now up on the year by 9.07% after a tremendous month of November saw it increase by 18.29%.1 That is the strongest ever monthly performance for the index.2 Monday, November 30th, saw a dip in the markets to close out the month as monthly rebalancing likely trimmed the equity exposure in portfolios and investors were eager to lock in the gains experienced in November.

IMPACT OF THE ELECTION AND THE VIRUS

A large part of the monthly gains can likely be attributed to two factors. The U.S. Presidential Election has led to political certainty and there was positive news surrounding a COVID-19 vaccine. Investors are in favor of the political certainty as President Elect Joe Biden was able to defeat President Donald Trump in the November 3rd election. President Trump continues to contest the election, but he has yet to have any significant wins in court. President Elect Biden named Janet Yellen as his pick for U.S. Treasury Secretary. It is not expected to face much resistance in the Senate; however, she will need 51 votes to be confirmed. If Republicans maintain their majority of 52 seats after the Georgia runoff, Democrats will need to swing 3 senators to confirm her. If she is confirmed, she will be the first female to hold the role. She will be a welcome sight for Progressives as she served as the Chair of the Federal Reserve during the former President Obama’s second term. She was later replaced by Jerome Powell as Chair after Trump’s 2016 campaign targeted her for keeping interest rates too low. Current Secretary Mnuchin said that he will work with his successor “if things get certified,” which should further put investors’ minds at ease.3


As the election results became clearer, so too, did news regarding vaccine trials. Pfizer, BioNTech, Moderna, and AstraZeneca all announced positive news regarding late stage trials of a vaccine.4 From the perspective of many investors, this positive news was able to outweigh the increased number of virus cases, thus causing markets to rally throughout the month. The image to the right shows the daily number of virus cases throughout the year.


The United Kingdom gave emergency authorization on Wednesday, December 2nd, to Pfizer’s coronavirus vaccine. This makes them the first Western country to approve a vaccine for distribution. With the vaccine being codeveloped by an American company, this authorization puts more pressure on U.S. regulators to move faster.6 Federal government officials are promising that a vaccine will come soon, and some have even said before Christmas.7 However, only a limited number of vaccines will be available for immediate distribution following any sort of approval. As a result, a plan must be put in place to best curb the spread of the virus and to protect those most at risk. In a recent meeting, the Centers for Disease Control and Prevention (CDC) voted on which groups of people will be the first to receive the vaccine. In a 13-to-1 vote, it was decided that health care workers and residents of nursing homes and other residential care facilities will be first in line.8 The rest of the country may have to wait until late spring or potentially even until the summer of 2021.7 While we still may be months away from a widely distributable vaccine, the recent news on effectiveness of the vaccines and the news from Britain shows us that there is a light at the end of the tunnel.

CONCLUSION

With all of the news surrounding the election, the virus, and the markets, it can be difficult, and certainly stressful contemplating your investments. The good news is that you shouldn’t have to make sense of it all. Your financial plans should be built based on your own risk tolerance and your own financial objectives. The ebbs and flows of the markets will come and go with each new headline and each passing day, but your portfolios should be built to withstand the volatility. We will inevitably experience more negative news surrounding the virus. There are likely to be more lockdowns in certain parts of the country and visiting family over Christmas could become more controversial than it was over the Thanksgiving break. There will be positive news too. Recent unemployment applications fell last week after a recent jump signaling that layoffs are easing, even though they remain high as the labor market continues to recover.10 More positive developments on the vaccine front are likely as well. The resulting short term market fluctuations may be tough to look at as they scroll across the bottom of your television, but it is important to remember that your money exposed to this risk is meant for longer term goals. Remember to maintain your disciplined investment approach and take the emotion out of investing. Understanding your portfolio is about understanding expectations. It’s about having a sense of how your portfolio is designed and how it should behave over meaningful periods of time. Having a sense of how the investments should react to certain movements in the market. Having a dynamic plan in place should put your mind at ease when volatility is high. Please don’t hesitate to reach out if you’d like to revisit your risk tolerance and asset allocation. It is important that you feel comfortable about your current portfolio as December is likely to continue with the volatility seen thus far in 2020.

1 https://www.investing.com/indices/

2 https://www.reuters.com/article/us-usa-stocks/sp-500-ends-down-after-rallying-to-best-november-ever-idUSKBN28A1MH

3 https://www.foxbusiness.com/markets/if-treasury-secretary-janet-yellen-make-history

4 https://www.cnbc.com/2020/12/01/world-stocks-outperform-the-us-in-bumper-november.html

5 https://covid.cdc.gov/covid-data-tracker/#trends_totalandratecases

6 https://www.nytimes.com/2020/12/02/world/europe/pfizer-coronavirus-vaccine-approved-uk.html

7 https://www.cnn.com/2020/11/30/health/covid-vaccine-questions-when/index.html

8 https://www.webmd.com/lung/news/20201201/cdc-votes-on-who-should-get-covid-vaccine-first

9 https://www.juliusbaer.com/es/insights/artificial-intelligence/the-robots-keep-coming-finance-gets-techier/

10 https://www.wsj.com/articles/weekly-jobless-claims-coronavirus-13-2-2020-11606950268

 21

Returns are based on the S&P 500 Total Return Index, an unmanaged, capitalization-weighted index that measures the performance of 500 large capitalization domestic stocks representing all major industries. Indices do not include fees or operating expenses and are not available for actual investment. The hypothetical performance calculations are shown for illustrative purposes only and are not meant to be representative of actual results while investing over the time periods shown. The hypothetical performance calculations for the respective strategies are shown gross of fees. If fees were included returns would be lower. Hypothetical performance returns reflect the reinvestment of all dividends. The hypothetical performance results have certain inherent limitations. Unlike an actual performance record, they do not reflect actual trading, liquidity constraints, fees and other costs. Also, since the trades have not actually been executed, the results may have under- or overcompensated for the impact of certain market factors such as lack of liquidity. Simulated trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. Returns will fluctuate and an investment upon redemption may be worth more or less than its original value. Past performance is not indicative of future returns. An individual cannot invest directly in an index.


This material has been prepared for information and educational purposes and should not be construed as a solicitation for the purchase or sell of any investment. The content is developed from sources believed to be reliable. This information is not intended to be investment, legal or tax advice. Investing involves risk, including the loss of principal. No investment strategy can guarantee a profit or protect against loss in a period of declining values. Investment advisory services offered by duly registered individuals on behalf of ChangePath, LLC a Registered Investment Adviser.

Index Returns (as of 11/30/2020) Level November QTD YTD
S&P 500 3621 10.75% 7.69% 12.10%
Dow Jones Industrial Average 29639 11.84% 6.68% 3.86%
NASDAQ Composite 12199 11.80% 9.23% 35.96%
Russell 2000 1820 18.29% 20.70% 9.07%
MSCI EAFE 2054 15.38% 10.70% 0.83%
MSCI Emerging Markets 1205 9.21% 11.37% 8.11%
U.S. Aggregate Bond - 0.98% 0.62% 7.36%

Source (1)

Source (5)

Source (9)

THE MARKET

After a strong start to the year, the S&P 500 fell just over 3% during the final week of January causing the index to finish the month down 1.11%. 

The Dow Jones Industrial Average (DJIA) followed suit and ended the month down 2.04% after also falling over 3% in the final week.1 It was a tale of two halves to begin the year as the markets initially reflected optimism regarding a new stimulus package from the Biden Administration and positivity regarding the vaccine roll out. The optimism was curbed as retail investors sparked unforeseen volatility in the equity markets causing a slight de-risking in portfolios during the last week of the month.


The technology heavy NASDAQ Composite continued to outperform relative to the S&P 500 and DJIA finishing the month up 1.42%. Small-cap stocks led equity markets in the United States as the Russell 2000 finished the month up 5.00%. Emerging markets also outperformed to start the year as the MSCI EM Index finished the month up 2.97% led by strong performance from China.1

THE ECONOMY

The United States’ economy continued to recover in the fourth quarter, but at a slower rate. After the record surge in the third quarter that saw GDP rise 33.4% on an annualized basis (a reflection of the drastic drop in the second quarter), fourth quarter estimates show a modest 4.0% annualized increase. The slowdown was a bit more than expected as the Covid-19 pandemic worsened towards the end of the year. Overall, U.S. GDP fell 3.5% annualized in 2020 which marks the first contraction since 2009 and the largest decrease since 1946.2


As new coronavirus infections hindered growth in the fourth quarter, it also led to a 140,000 decrease in non-farm payroll jobs for the month of December which was much lower than the expected increase of 50,000.4 This led to a slight increase in initial jobless claims in January as 847,000 new claims were filed for the week ending on January 23rd. For reference, weekly jobless claims were closer to 200,000 prior to the pandemic.5 As the non-farm payroll jobs decreased and the pandemic worsened to end the year, personal consumption finished lower than expected at a 2.5% increase.6 All in all, the economy is healing, just slightly slower than expected.


The month of January started with great political tension as the Georgia Senate run-off was held on January 5th followed by the Capitol Hill riots the next day as Congress met to certify the Presidential Election. Ultimately, the Democrats emerged victorious in both Georgia Senate races to take control of the Senate (the Senate is now split 50/50 with Vice President Kamala Harris holding the tiebreaking vote). The Presidential Election was eventually certified late in the evening on January 6th and President Joe Biden took office on January 20th. He began his term in office with numerous executive orders that will greatly impact our country moving forward. While there is still a political divide in our country, we believe the political certainty provided during the month of January can be seen as a good thing for both the economy and markets.


Even with the economy growing at a slightly slower pace than expected in the fourth quarter, there is optimism moving forward as it relates to the vaccine, monetary policy, and fiscal policy. As of February 3rd, over 33 million Americans have received the Covid-19 vaccine whether it be from Moderna of Pfizer.7 There has also been positive news on the Johnson & Johnson single shot vaccine which should only help increase the speed of getting the vaccine to more Americans.8 The Biden Administration announced details of a $1.9 trillion-dollar Covid-19 relief plan titled the American Rescue Plan. This large amount is unlikely to be passed as it requires a 60-vote approval in the Senate meaning that 10 Republican Senators would have to agree to it. It’s possible the Democrats use a special reconciliation process to only require a simple majority to pass the bill.9 However, common ground may be found closer to the $1 trillion range considering Republicans countered Biden’s plan with a $618 million package.10 Lastly, the Federal Reserve stated that they will keep target interest rates at 0 – 0.25% through at least 2023 and will maintain their monthly bond purchases likely through the end of 2021 in order for the economic recovery to continue.11

CONCLUSION

The month of January seemed to be a continuation of 2020 with the political divide at the beginning the month and the retail investor frenzy to end the month, but there is an overall sense that we are getting closer to pre-virus norms. We believe equity markets should continue their momentum from the second half of 2020 supported by continued economic growth, improved earnings from companies affected by the pandemic, and support from both monetary and fiscal policy. We must continue to persevere through the pandemic as Covid-19 is still very much a risk with unknowns surrounding other strains. Thus, the recovery could continue to move along slower than expected. It is possible further stimulus is hindered by the 50/50 split in the Senate and we are still in a headline driven society that lends itself to market volatility. Because of this, we believe it is wise to continue to maintain a well-diversified balanced approach to investing based on your risk tolerance. The focus is still on quality in the United States, and as the global economic recovery continues, we believe that there are opportunities in international equities and all market caps in the United States as evidenced by the recent performance in small cap. If you’d like to revisit the holdings in your portfolio or update your risk tolerance and objectives in the New Year, don’t hesitate to reach out and schedule a meeting today.

1 https://www.investing.com/indices/major-indices

2 https://www.reuters.com/article/us-usa-economy/covid-19-savages-u-s-economy-2020-performance-worst-in-74-years-idUSKBN29X0I8

3 https://finance.yahoo.com/news/4q-gdp-2020-us-economy-coronavirus-pandemic-180133456.html

4 https://www.bls.gov/opub/ted/2021/payroll-employment-down-140000-in-december-2020.htm?view_full

5 https://finance.yahoo.com/news/initial-jobless-claims-for-week-ending-jan-23-001546390.html

6 https://www.thebalance.com/consumer-spending-trends-and-current-statistics-3305916

7 https://www.statista.com/statistics/1194931/covid-vaccine-doses-administered-by-state-us/

8 https://www.bbc.com/news/health-55857530

9 https://www.cbsnews.com/news/stimulus-covid-relief-democrats-1-9-trillion-plan/

10 https://www.forbes.com/advisor/personal-finance/gop-proposal-1000-stimulus-checks/

11 https://www.usatoday.com/story/money/2021/01/27/fed-interest-rates-fed-keeps-key-rate-near-zero-maintains-bond-purchases/4278894001/

12 https://www.juliusbaer.com/es/insights/artificial-intelligence/the-robots-keep-coming-finance-gets-techier/

Returns are based on the S&P 500 Total Return Index, an unmanaged, capitalization-weighted index that measures the performance of 500 large capitalization domestic stocks representing all major industries. Indices do not include fees or operating expenses and are not available for actual investment. The hypothetical performance calculations are shown for illustrative purposes only and are not meant to be representative of actual results while investing over the time periods shown. The hypothetical performance calculations for the respective strategies are shown gross of fees. If fees were included returns would be lower. Hypothetical performance returns reflect the reinvestment of all dividends. The hypothetical performance results have certain inherent limitations. Unlike an actual performance record, they do not reflect actual trading, liquidity constraints, fees and other costs. Also, since the trades have not actually been executed, the results may have under- or overcompensated for the impact of certain market factors such as lack of liquidity. Simulated trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. Returns will fluctuate and an investment upon redemption may be worth more or less than its original value. Past performance is not indicative of future returns. An individual cannot invest directly in an index.


This material has been prepared for information and educational purposes and should not be construed as a solicitation for the purchase or sell of any investment. The content is developed from sources believed to be reliable. This information is not intended to be investment, legal or tax advice. Investing involves risk, including the loss of principal. No investment strategy can guarantee a profit or protect against loss in a period of declining values. Investment advisory services offered by duly registered individuals on behalf of ChangePath, LLC a Registered Investment Adviser.

Level MTD/QTD/YTD
S&P 500 3,714.24 -1.11 %
Dow Jones Industrial Average 29,982.62 -2.04%
NASDAQ Composite 13,070.70 1.42%
Russell 2000 2,073.64 5.00 %
MSCI EAFE 2,124.05 -1.09%
MSCI Emerging Markets 1,329.57 2.97%
U.S. Aggregate Bond - -0.72%

Source (1)

Source – Bureau of Economic Analysis (3)

Source – U.S. Department of Labor (5)

Source (12)

03 Dec, 2021
November was a dizzying month for investors. The highlight? Earnings. 82% of companies1 beat estimates this quarter, despite headwinds such as supply chain constraints and inflation. The market’s biggest muse? Elon Musk’s twitter handle, with tweets such as (paraphrased) “should I sell 10% of my Tesla stock?” The most exciting job? Fed watcher. We started tapering, saw a plethora of hot inflation data, and gleaned insight from Federal Reserve Chair Jerome Powell on the last day of the month. November 2021 Market Returns 
03 Dec, 2021
October was another positive month for the markets after September’s pullback. So far in 2021, the S&P 500 had nine positive performing months, September being the only hold out. The index ended up 6.9%, even though the first week of the month started a bit volatile. However, 2021 is looking robust, even if November and December aren’t large contributors, as the YTD performance through October is 23.9%. 1 
By Rob Kellogg, CFA® 07 Oct, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 07 Sep, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 05 Aug, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 05 Jun, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 07 May, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 05 May, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 08 Apr, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 09 Mar, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
More Posts
Share by: